1. Home
  2. BNZI vs ADVB Comparison

BNZI vs ADVB Comparison

Compare BNZI & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.12

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$4.57

Market Cap

109.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
ADVB
Founded
2016
2014
Country
United States
United States
Employees
28
31
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
109.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
ADVB
Price
$1.12
$4.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$23.00
N/A
AVG Volume (30 Days)
804.5K
124.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$185.61
N/A
Revenue Next Year
$32.86
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.19
52 Week High
$4.44
$5.69

Technical Indicators

Market Signals
Indicator
BNZI
ADVB
Relative Strength Index (RSI) 43.78 90.63
Support Level $1.07 $0.41
Resistance Level $1.40 $5.69
Average True Range (ATR) 0.11 0.52
MACD -0.01 0.29
Stochastic Oscillator 20.00 77.97

Price Performance

Historical Comparison
BNZI
ADVB

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: